62
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Increased Risk of Celiac Disease in Patients with Uveitis

, BScORCID Icon, , BA, BS, MA, , MD, , MD, , MD, , MD, , MD, , MD & , MD show all
Received 19 May 2023, Accepted 28 Jul 2023, Published online: 14 Aug 2023

References

  • Nian H, Liang D, Zuo A, Wei R, Shao H, Born WK, et al. Characterization of autoreactive and bystander IL-17+ T cells induced in immunized C57BL/6 mice. Invest Ophthalmol Vis Sci. 2012;53(2):897–905. doi:10.1167/iovs.11-8297.
  • Al-Dhibi HA, Al-Mahmood AM, Arevalo JF. A systematic approach to emergencies in uveitis. Middle East Afr J Ophthalmol. 2014;21(3):251–258. doi:10.4103/0974-9233.134687.
  • Pato E, Muñoz-Fernández S, Francisco F, Abad MA, Maese J, Ortiz A, et al. Systematic review on the effectiveness of immunosuppressants and biological therapies in the treatment of autoimmune posterior uveitis. Semin Arthritis Rheumatism. 2011;40(4):314–323. doi:10.1016/j.semarthrit.2010.05.008.
  • José-Vieira R, Ferreira A, Menéres P, Sousa-Pinto B, Figueira L. Efficacy and safety of intravitreal and periocular injection of corticosteroids in noninfectious uveitis: a systematic review. Surv Ophthalmol. 2022;67(4):991–1013. doi:10.1016/j.survophthal.2021.12.002.
  • Mayhew RGE, Li T, McCann P, Leslie L, Caldwell AS, Palestine AG. Non‐biologic, steroid‐sparing therapies for non‐infectious intermediate, posterior, and panuveitis in adults. Cochrane Database Syst Rev. 2022;10(10):CD014831.
  • Gaggiano C, Sota J, Gentileschi S, Caggiano V, Grosso S, Tosi GM, et al. The current status of biological treatment for uveitis. Expert Rev Clin Immunol. 2020;16(8):787–811. doi:10.1080/1744666X.2020.1798230.
  • Gritz DC, Wong IG. Incidence and prevalence of uveitis in Northern California: The Northern California epidemiology of uveitis study. Ophthalmology. 2004;111(3):491–500. doi:10.1016/j.ophtha.2003.06.014.
  • Joltikov KA, Lobo-Chan AM. Epidemiology and risk factors in non-infectious uveitis: a systematic review. Front Med (Lausanne). 2021;8:695904. doi10.3389/fmed.2021.695904.
  • Vivas S, Ruiz de Morales JM, Fernandez M, Hernando M, Herrero B, Casqueiro J, et al. Age-related clinical, serological, and histopathological features of celiac disease. Am J Gastroenterol. 2008;103(9):2360–2365. doi:10.1111/j.1572-0241.2008.01977.x.
  • Reilly NR, Aguilar K, Hassid BG, Cheng J, Defelice AR, Kazlow P, et al. Celiac disease in normal-weight and overweight children: clinical features and growth outcomes following a gluten-free diet. J Pediatr Gastroenterol Nutr. 2011;53(5):528–531. doi:10.1097/MPG.0b013e3182276d5e.
  • Leffler DA, Green PHR, Fasano A. Extraintestinal manifestations of coeliac disease. Nat Rev Gastroenterol Hepatol. 2015;12(10):561–571. doi:10.1038/nrgastro.2015.131.
  • Husby S, Koletzko S, Korponay-Szabó IR, Mearin ML, Phillips A, Shamir R, et al. European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54(1):136–160. doi:10.1097/MPG.0b013e31821a23d0.
  • Caio G, Volta U, Sapone A, Leffler DA, De Giorgio R, Catassi C, et al. Celiac disease: a comprehensive current review. BMC Med. 2019;17(1):142. doi:10.1186/s12916-019-1380-z.
  • Ivarsson A, Persson LA, Juto P, Peltonen M, Suhr O, Hernell O. High prevalence of undiagnosed coeliac disease in adults: a Swedish population-based study. J Intern Med. 1999;245(1):63–68. doi:10.1046/j.1365-2796.1999.00403.x.
  • Riestra S, Fernández E, Rodrigo L, Garcia S, Ocio G. Prevalence of Coeliac disease in the general population of northern Spain: Strategies of serologic screening. Scand J Gastroenterol. 2000;35(4):398–402. doi:10.1080/003655200750023967.
  • Bach JF. The hygiene hypothesis in autoimmunity: the role of pathogens and commensals. Nat Rev Immunol. 2018;18(2):105–120. doi:10.1038/nri.2017.111.
  • Mustalahti K, Catassi C, Reunanen A, Fabiani E, Heier M, McMillan S, et al. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med. 2010;42(8):587–595. doi:10.3109/07853890.2010.505931.
  • Rubio-Tapia A, Ludvigsson JF, Brantner TL, Murray JA, Everhart JE. The prevalence of celiac disease in the United States. Am J Gastroenterol. 2012;107(10):1538–1544. quiz 1537, 1545. doi:10.1038/ajg.2012.219.
  • Corazza GR, Andreani ML, Biagi F, Corrao G, Pretolani S, Giulianelli G, et al. The smaller size of the “coeliac iceberg” in adults. Scand J Gastroenterol. 1997;32(9):917–919. doi:10.3109/00365529709011202.
  • Kori M, Zamir Y, Yermiyahu SO, Ainbinder I, Daichman S, Pinto GD, et al. The association of inflammatory bowel disease with celiac disease and celiac autoimmunity in children and adults: A nationwide study from the epi-IIRN. J Crohns Colitis. 2022;17:700–705. doi:10.1093/ecco-jcc/jjac176.
  • Fasano A, Catassi C. Clinical practice: Celiac disease. N Engl J Med. 2012;367(25):2419–2426. doi:10.1056/NEJMcp1113994.
  • Ghanchi FD, Rembacken BJ. Inflammatory bowel disease and the eye. Surv Ophthalmol. 2003;48(6):663–676. doi:10.1016/j.survophthal.2003.08.004.
  • Mollazadegan K, Kugelberg M, Tallstedt L, Ludvigsson JF. Increased risk of uveitis in coeliac disease: a nationwide cohort study. British J Ophthalmol. 2012;96(6):857–861. doi:10.1136/bjophthalmol-2011-301051.
  • Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol | ACG. 2013;108(5):656. doi:10.1038/ajg.2013.79.
  • Bonamico M, Ferri M, Mariani P, Nenna R, Thanasi E, Luparia RPL, et al. Serologic and genetic markers of celiac disease: a sequential study in the screening of first degree relatives. J Pediatr Gastroenterol Nutr. 2006;42(2):150–154. doi:10.1097/01.mpg.0000189337.08139.83.
  • Vitoria JC, Arrieta A, Astigarraga I, García-Masdevall D, Rodriguez-Soriano J. Use of serological markers as a screening test in family members of patients with celiac disease. J Pediatr Gastroenterol Nutr. 1994;19(3):304–309. doi:10.1097/00005176-199410000-00008.
  • Ludvigsson JF, Leffler DA, Bai JC, Biagi F, Fasano A, Green PHR, et al. The Oslo definitions for coeliac disease and related terms. Gut. 2013;62(1):43–52. doi:10.1136/gutjnl-2011-301346.
  • Lundin KEA, Wijmenga C. Coeliac disease and autoimmune disease-genetic overlap and screening. Nat Rev Gastroenterol Hepatol. 2015;12(9):507–515. doi:10.1038/nrgastro.2015.136.
  • Pinto-Sanchez MI, Seiler CL, Santesso N, Alaedini A, Semrad C, Lee AR, et al. Association between inflammatory bowel diseases and celiac disease: a systematic review and meta-analysis. Gastroenterology. 2020;159(3):884–903.e31. doi:10.1053/j.gastro.2020.05.016.
  • Coutinho AE, Chapman KE. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol. 2011;335(1):2–13. doi:10.1016/j.mce.2010.04.005.
  • Bascones-Martinez A, Mattila R, Gomez-Font R, Meurman JH. Immunomodulatory drugs: oral and systemic adverse effects. Med Oral Patol Oral Cir Bucal. 2014;19(1):e24–31. doi:10.4317/medoral.19087.
  • Rubio-Tapia A, Abdulkarim AS, Wiesner RH, Moore SB, Krause PK, Murray JA. Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantation. Liver Int. 2008;28(4):467–476. doi:10.1111/j.1478-3231.2008.01681.x.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.